Physician profile
Amit A Patel
NPI 1932330198
$11,827.93
in general payments reported to CMS, 2019-2025
50 companies · $1,843 in 2025
The $1,843 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,376 · 2022: $1,992 · 2023: $3,733 · 2024: $1,885 · 2025: $1,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,719 · Travel and Lodging: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,718.96 |
| Travel and Lodging | $740.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,942.50 | 2021-2025 | |
| Relievant Medsystems, INC. | $1,228.70 | 2022-2023 | Intracept |
| Collegium Pharmaceutical, INC. | $1,031.89 | 2021-2025 | Belbuca, Xtampza |
| Biohaven Pharmaceuticals, INC. | $1,024.56 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $779.89 | 2021-2025 | Relistor |
| Boston Scientific Corporation | $653.97 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $561.53 | 2021-2025 | |
| Saluda Medical Americas, INC. | $419.71 | 2024-2025 | Evoke |
| Abbott Laboratories | $374.07 | 2022-2025 | Proclaim, Eterna |
| Zavation Medical Products, LLC | $291.41 | 2023-2024 | |
| Protega Pharmaceutials INC | $272.66 | 2023-2024 | Roxybond |
| Biohaven Pharmaceutical Holding Company LTD. | $262.05 | 2022 | |
| Lundbeck LLC | $238.69 | 2021-2025 | Vyepti |
| Amgen INC. | $236.33 | 2021-2025 | Krystexxa, Evenity, Prolia |
| Nevro Corp. | $231.38 | 2021-2024 | Senza |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $205.26 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Scilex Pharmaceuticals INC. | $193.63 | 2021-2025 | Ztlido |
| Redhill Biopharma INC. | $156.76 | 2021-2022 | |
| Grt US Holding, INC. | $128.53 | 2022 | |
| Averitas Pharma INC. | $121.09 | 2023-2024 | Qutenza |
| Almatica Pharma LLC | $115.37 | 2021-2023 | Gralise |
| Lilly USA, LLC | $108.54 | 2021-2023 | Reyvow, Emgality |
| Vertos Medical, INC. | $107.89 | 2021-2023 | Mild Device Kit |
| Pacira Therapeutics, INC. | $105.51 | 2021 | |
| Curiteva, INC. | $95.25 | 2021 | |
| Axsome Therapeutics, INC. | $90.52 | 2025 | Symbravo |
| Ibsa Pharma INC. | $77.90 | 2021-2024 | Tirosint, Flector, Licart |
| Mml US, INC. | $76.61 | 2025 | Reactiv8 |
| Allergan, INC. | $68.82 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $63.35 | 2021-2022 | |
| Horizon Therapeutics Plc | $60.52 | 2021-2023 | Krystexxa |
| Si-Bone, INC. | $52.58 | 2023-2024 | |
| Spinal Simplicity, LLC | $48.95 | 2022-2025 | Ha Minuteman G3-R |
| Electronic Waveform Lab, INC. | $46.34 | 2024-2025 | |
| Cumberland Pharmaceuticals, INC. | $31.77 | 2024 | Kristalose |
| Alnylam Pharmaceuticals INC. | $31.40 | 2023-2024 | Givlaari |
| Amneal Pharmaceuticals LLC | $30.68 | 2023 | Lyvispah |
| International Rehabilitative Sciences, INC | $29.66 | 2024 | Rs 4i Plus Sequential Stimulator |
| Radius Health, INC. | $28.56 | 2023 | Tymlos |
| Biodelivery Sciences International, INC. | $24.62 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $23.53 | 2025 | |
| Curonix LLC | $23.08 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ultragenyx Pharmaceutical INC. | $19.82 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.89 | 2021 | |
| Valinor Pharma, LLC | $17.39 | 2025 | Movantik |
| Arbor Pharmaceuticals, INC. | $17.30 | 2021 | |
| Nalu Medical, INC. | $16.16 | 2022 | |
| Fidia Pharma USA INC. | $15.92 | 2023 | Hymovis, Triluron |
| Hikma Pharmaceuticals USA | $14.83 | 2023 | Kloxxado |
| Virtus Pharmaceuticals LLC | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.